# ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)

> **NCT02931175** · PHASE2 · COMPLETED · sponsor: **Quan Dong Nguyen** · enrollment: 28 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** ACTH gel

## Key facts

- **NCT ID:** NCT02931175
- **Lead sponsor:** Quan Dong Nguyen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-10
- **Primary completion:** 2020-04-03
- **Final completion:** 2021-10-28
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02931175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02931175, "ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02931175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*